Johnson & Johnson logo

JNJ

Johnson & Johnson

HealthcareDrug Manufacturers$495B Market Cap

Pharmaceuticals, medical devices, consumer health products. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
65%Neutral
Buy/Sell Ratio69% buys
BearishBullish
Johnson & Johnson Live QuoteReal-time
$267.14
+$9.36(+3.63%)1M
Day Range$264.68 – $270.60
Open$269.61
Previous Close$272.70
Volume9.84M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$643.09B
P/E Ratio (TTM)40.5
Forward P/E23.0
EPS (TTM)$6.59
Price to Book8.1
Dividend Yield1.94%
Beta (Volatility)0.20
IndustryDRUG MANUFACTURERS - GENERAL
52-Week RangeCurrent: $267.14 (75%)
Low: $196.75High: $290.25
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$279.17+36.0% upside

Insider Buys

13

$63.69M

Insider Sales

6

$29.19M

Total Volume

$92.88M

42 transactions

Net Activity

+$34.49M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Moderate accumulation: purchases represent 69% of total transaction value.
  • •Cluster buying: 5 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
J
1

Joaquin Duato

CEO

3 buys1 sells

$23.71M total

J
2

Joseph Wolk

CFO

4 buys0 sells

$21.73M total

V
3

VP Operations

VP

3 buys0 sells

$15.73M total

C
4

Chief Operating Officer

COO

1 buys2 sells

$15.65M total

B
5

Board Director

Dir

2 buys2 sells

$12.34M total

Trading History
JNJ insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 12, 2026

1 weeks ago

Forminard Elizabeth

EVP, GC

EVP
Sell13.1K$284.39$3.72M

Oct 24, 2026

3 weeks ago

Joseph Wolk

CFO

CFO
Buy43.9K$212.42$9.33M

Oct 22, 2026

4 weeks ago

Joaquin Duato

CEO

CEO
Buy34.0K$196.95$6.69M

Oct 19, 2026

1 months ago

Joseph Wolk

CFO

CFO
Buy26.9K$204.64$5.50M

Oct 16, 2026

1 months ago

VP Operations

VP

VP
Buy30.9K$207.16$6.41M

Oct 18, 2026

1 months ago

VP Operations

VP

VP
Buy13.6K$214.65$2.92M

Oct 18, 2026

1 months ago

Chief Operating Officer

COO

COO
Buy23.5K$203.27$4.77M

Oct 14, 2026

1 months ago

Joseph Wolk

CFO

CFO
Buy29.6K$202.83$6.01M

Oct 15, 2026

1 months ago

Chief Operating Officer

COO

COO
Sell45.0K$206.06$9.28M

Oct 12, 2026

1 months ago

Joseph Wolk

CFO

CFO
Buy4.3K$205.75$889K

Oct 10, 2026

1 months ago

Joaquin Duato

CEO

CEO
Buy4.3K$207.52$895K

Oct 8, 2026

1 months ago

Board Director

Dir

Director
Buy10.6K$211.38$2.25M

Oct 6, 2026

1 months ago

Joaquin Duato

CEO

CEO
Buy31.3K$206.23$6.45M

Oct 3, 2026

1 months ago

Chief Operating Officer

COO

COO
Sell8.1K$197.18$1.59M

Oct 2, 2026

1 months ago

VP Operations

VP

VP
Buy32.2K$198.54$6.40M

Sep 30, 2026

1 months ago

Board Director

Dir

Director
Sell3.4K$207.92$704K

Sep 29, 2026

1 months ago

Board Director

Dir

Director
Buy25.8K$200.07$5.17M

Sep 30, 2026

1 months ago

Board Director

Dir

Director
Sell20.9K$202.38$4.23M

Sep 21, 2026

2 months ago

Joaquin Duato

CEO

CEO
Sell46.8K$206.71$9.67M

Sep 2, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell26.3K$-33597.00$0

Aug 17, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell194.5K$-15000.00$0

Aug 13, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell307.8K$-123291.00$0

Aug 5, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell307.8K$-48480.00$0

Aug 6, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell17.0K$-15918.00$0

Jul 20, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell23.0K$-23054.00$0

Jun 11, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell114.7K$-10000.00$0

Feb 27, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell24.5K$-4075.00$0

Feb 20, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell26.2K$-1322.00$0

Feb 18, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell27.6K$-22623.00$0

Feb 13, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell25.7K$-62080.00$0

Feb 17, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell85.0K$-89654.00$0

Jan 26, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell307.8K$-100000.00$0

Nov 26, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.8K$1250.00$2.31M

Oct 17, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell10.7K$-21721.00$0

Sep 4, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell178.0K$-56471.00$0

Aug 22, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell407.8K$-125824.00$0

Aug 15, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell85.0K$-16820.00$0

Jul 17, 2025

16 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell10.7K$-19137.00$0

Feb 25, 2025

21 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell21.8K$-6999.00$0

Feb 18, 2025

21 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.1K$-403.00$0

Feb 7, 2025

21 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell70.9K$-13015.00$0

Dec 12, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.0K$1000.00$1.00M
Sector & Industry Benchmarks
Healthcare Comparison Overview
Industry Buy Conviction0%
JNJ Buy Conviction69%
Industry Rank#1 of 1
Volume Contribution2498.4%
Total Industry Activity$3.72M

JNJ has an insider buy conviction of 69%, compared to the Healthcare sector buy average of 0%. JNJ ranks #1 in insider activity out of 1 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for JNJ

Over the last 90 days, corporate insiders at Johnson & Johnson (JNJ) engaged in a total of 42 transactions reported via SEC Form 4 filings. Among these, 13 were open-market purchases and 6 were sales. The total volume of insider trading reached $92.88M.

The net insider activity for JNJ shows a net buying bias of $34.49M. This activity represents a 69% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Joaquin Duato (CEO), who traded 46.8K shares valued at $9.67M on Sep 21, 2026.

Live Market News & Developments
Aggregated real-time headlines for Johnson & Johnson (JNJ)
6 updates

Johnson & Johnson stock falls despite strong earnings as investors focus on medtech unit

Yahoo Finance38d ago

Jim Cramer says J&J is a 'metaphor for what's working' in the stock market

CNBC3d ago

Johnson & Johnson's arthritis drug reduced inflammation near the spine more than twice as much as a placebo did.

Stock Titan5h ago

Guggenheim Names Top Biotech Stock Pick Following JNJ Latest Deal

Investing.com3d ago

Stock Screening Made Simple: A Closer Look

Zacks Investment Research18h ago

Why Is JNJ Stock Beating Rivals That Grow Faster?

Trefis59d ago

Explore Peers in Drug Manufacturers

Compare insider activity and sentiment scores across similar organizations.

FAQs About Johnson & Johnson Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for JNJ.

Based on SEC Form 4 disclosures, the Insider Confidence Score for JNJ is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 13 purchases and 6 sales by company executives over the last 90 days.

The CEO Conviction Index for JNJ is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.